In contrast, replacement with moderate physiological doses of GCs appears to prevent degenerative changes and support the survival and integration of newborn neurons in the DG
Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice
CAR activates the SIRT1 pathway and inhibits the p38 MAPK signaling pathway, reducing NLRP3 inflammasome production and alleviating inflammation and cartilage degeneration (Li S et al., 2023)
Remember that lifestyle changes alongside medication drive the best results across any timeline
In rough trial comparisons, Retatrutides TRIUMPH-1 data shows around 28.3% mean weight loss at 80 weeks on the 12 mg dose, with up to 30.3% at 104 weeks in a select extension population
This mitochondrial support may also contribute to healthy aging, as mitochondrial dysfunction is a hallmark of cellular aging
